Project cooperationUpdated on 22 December 2025
Postbitic for glycemic control (type 2 diabetes, prediabetes)
R&D Manager at GENBIOMA
Pamplona, Spain
About
Genbioma is a start-up that studies the microbiome to create products that improve cardiometabolic health.
Health Solutions
Genbioma advances metabolic wellness with postbiotic ingredients that restores gut-microbiota balance to steady glucose, harmonise lipid profiles and support healthy weight. Our most advanced product is intended for type 2 diabetes and prediabetes. Other products in our pipeline are aimed at lipid metabolism.
Research platform
Genbioma has validated a development platform for rapid identification and functional profiling of new microbiome-based solutions.
-
Array of validated assays for glucose, lipid and cardiovascular metabolism using C. elegans model.
-
Integrated metagenomics & metabolomics to unveil mode-of-action early.
-
Regulatory filters baked in: Safety, IP and regulatory checkpoints for early candidate de-selection.
Expertise
Microbiome study. Postbiotics, probiotics. Preclinical and clinical studies. Metagenomics.
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
Jordi Mayneris Perxachs
Group Leader - R4 at GIRONA BIOMEDICAL RESEARCH CENTRE (IDIBGI)
Girona, Spain
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
MARTA SANS VALLS
European Programme Manager at Fundacio Eurecat
Barcelona, Spain
Project cooperation
Vascular Biology and Metabolic Regulation in Cardiometabolic Diseases
- Partner seeks Consortium/Coordinator
Andrea Szuchman-Sapir
Head of vascular signaling group at Migal
Kiryat Shmona, Israel